Haemonetics Corporation Common Stock (NY:HAE)

119.75 +1.43 (+1.20%)

Delayed Quote Updated: 2:36 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More ↗

May 09, 2022

Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:...

Via Benzinga

Analyst Ratings For Haemonetics ↗

February 09, 2022

Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter:

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

February 09, 2022

Cowen & Co. cut the price target on Chipotle Mexican Grill, Inc. (NYSE: CMG) from $2,250 to $1,950. Chipotle shares rose 6.1% to $1,549.97 in pre-market trading.

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Surges 100 Points; Graham Shares Plunge ↗

February 08, 2022

US stocks extended gains later in the session, with the Nasdaq index surging 100 points on Tuesday.

Via Benzinga

Why Haemonetics Shares Are Trading Higher Today? ↗

February 08, 2022

Haemonetics Corporation (NYSE: HAE) posted

Via Benzinga

Recap: Haemonetics Q3 Earnings ↗

February 08, 2022

Haemonetics (NYSE:HAE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

51 Biggest Movers From Yesterday ↗

February 09, 2022

Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 08, 2022

Gainers BioCardia (NASDAQ:BCDA) stock inc...

Via Benzinga

Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher ↗

February 08, 2022

US stocks remained mostly higher on Tuesday, while the S&P 500 traded lower by 0.1%.

Via Benzinga

35 Stocks Moving In Tuesday's Mid-Day Session ↗

February 08, 2022

Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗

February 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

64 Biggest Movers From Yesterday ↗

January 28, 2022

Check out these penny stocks insiders are buying Losers ION Geophysical Corporation (NYSE: IO) shares fell 53.6% to settle at $0.51 on Thursday. Epizyme, Inc. (NASDAQ:...

Via Benzinga

Earnings Scheduled For February 8, 2022 ↗

February 08, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Via Benzinga

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

75 Biggest Movers From Yesterday ↗

November 10, 2021

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers...

Via Benzinga

46 Stocks Moving In Thursday's Mid-Day Session ↗

January 27, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling...

Via Benzinga

Why Haemonetics Stock Dived by 15% Today ↗

November 09, 2021

The company broadly meets expectations for its Q2 2022 but trims its full-year guidance.

Via The Motley Fool

Haemonetics Corp (HAE) Q2 2022 Earnings Call Transcript ↗

November 09, 2021

HAE earnings call for the period ending October 2, 2021.

Via The Motley Fool

Topics Earnings

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022 ↗

January 27, 2022

Upgrades

Via Benzinga

Looking Into Haemonetics's Return On Capital Employed ↗

November 09, 2021

According to Benzinga Pro, during Q2, Haemonetics (NYSE:HAE) earned $24.51 million, a 398.43% increase from the preceding quarter. Haemonetics also posted a total of $239.90...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 09, 2021

Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 ↗

December 15, 2021

Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:

Via Benzinga

58 Stocks Moving In Monday's Mid-Day Session ↗

November 09, 2021

Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash. TDH...

Via Benzinga

Haemonetics' Vascade Vascular Closure Device Includes Same-Day Discharge Label ↗

October 01, 2021

Haemonetics Corp's (NYSE: HAE) Vascade MVP Venous Vascular Closure System becomes the first vascular closure device to receive FDA indication for same-day discharge...

Via Benzinga

Looking into Haemonetics's Return on Capital Employed ↗

August 11, 2021

After pulling data from Benzinga Pro it seems like during Q1, Haemonetics (NYSE:HAE) posted sales of $228.53 million. Earnings were up 61.57%, but Haemonetics still reported an...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Haemonetics Corp (HAE) Q1 2022 Earnings Call Transcript ↗

August 11, 2021

HAE earnings call for the period ending July 3, 2021.

Via The Motley Fool

Topics Earnings

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.